Celon Pharma S.A. (WSE: CLN)
Poland flag Poland · Delayed Price · Currency is PLN
25.00
-0.30 (-1.19%)
Jan 21, 2025, 5:04 PM CET

Celon Pharma Balance Sheet

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
24.9232.3682.9147.843.9866.69
Upgrade
Short-Term Investments
78.3682.1881.7279.76--
Upgrade
Cash & Short-Term Investments
103.28114.54164.62227.5543.9866.69
Upgrade
Cash Growth
1.31%-30.42%-27.65%417.42%-34.06%-54.94%
Upgrade
Accounts Receivable
49.9832.7927.1124.6732.5339.18
Upgrade
Other Receivables
1.5515.456.592.579.496.6
Upgrade
Receivables
51.5348.2433.727.2542.0245.78
Upgrade
Inventory
27.5426.4138.3923.3829.7630.06
Upgrade
Other Current Assets
10.910.560.870.533.481.04
Upgrade
Total Current Assets
193.26189.75237.58278.7119.24143.58
Upgrade
Property, Plant & Equipment
315.8333.8341.59316.57313.8230.08
Upgrade
Long-Term Investments
80.8211.4213.2538.1212.8748.53
Upgrade
Other Intangible Assets
10.2114.2921.1527.8138.382.08
Upgrade
Long-Term Deferred Tax Assets
18.8119.0528.1431.9427.1711.5
Upgrade
Long-Term Deferred Charges
-0.680.681.362.724.08
Upgrade
Other Long-Term Assets
0.250.320.3812.6417.7151.5
Upgrade
Total Assets
619.15569.31642.76707.14531.89591.35
Upgrade
Accounts Payable
14.5510.5117.4711.8718.427.36
Upgrade
Accrued Expenses
7.267.396.83.116.771.49
Upgrade
Short-Term Debt
-12.75--12.84-
Upgrade
Current Portion of Leases
7.137.1319.436.563.491.47
Upgrade
Current Income Taxes Payable
-----1.02
Upgrade
Current Unearned Revenue
21.431.0956.4255.8345.783.11
Upgrade
Other Current Liabilities
21.9417.4816.328.9926.8611.53
Upgrade
Total Current Liabilities
72.2786.34116.4486.36114.1525.98
Upgrade
Long-Term Leases
7.25.717.398.359.160.19
Upgrade
Long-Term Unearned Revenue
20.822.8825.6229.8539.67108.62
Upgrade
Long-Term Deferred Tax Liabilities
2.643.011.326.04-11.51
Upgrade
Other Long-Term Liabilities
-5.8112.3522.5324.380
Upgrade
Total Liabilities
102.91123.75163.12153.14187.36146.31
Upgrade
Common Stock
45.625.115.15.14.54.5
Upgrade
Additional Paid-In Capital
511.02543.23587.1613.51393.12234.45
Upgrade
Retained Earnings
-47.03-108.64-119.79-91.67-58.57172.34
Upgrade
Comprehensive Income & Other
6.645.857.2327.075.4833.75
Upgrade
Shareholders' Equity
516.25445.56479.65554344.53445.04
Upgrade
Total Liabilities & Equity
619.15569.31642.76707.14531.89591.35
Upgrade
Total Debt
14.3325.5926.8214.9225.481.66
Upgrade
Net Cash (Debt)
88.9688.95137.8212.6318.565.03
Upgrade
Net Cash Growth
4.24%-35.45%-35.19%1049.56%-71.56%-56.06%
Upgrade
Net Cash Per Share
1.681.742.704.550.411.45
Upgrade
Filing Date Shares Outstanding
53.8651.0651.04514545
Upgrade
Total Common Shares Outstanding
53.8651.0651.04514545
Upgrade
Working Capital
120.99103.41121.14192.345.1117.6
Upgrade
Book Value Per Share
9.598.739.4010.867.669.89
Upgrade
Tangible Book Value
506.03431.26458.5526.19306.16442.96
Upgrade
Tangible Book Value Per Share
9.408.458.9810.326.809.84
Upgrade
Land
6.356.356.356.356.356.35
Upgrade
Buildings
161.64146.4146.35146.08173.554.94
Upgrade
Machinery
247.5198.61190.43177.34164.34148.3
Upgrade
Construction In Progress
14.8279.9574.350.6331.595.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.